Company Profile

In 2015, Secarna was founded by a team of highly experienced biotech professionals and investors. The company is located in Munich/Germany where we have established our discovery and development unit with more than 2.000 square feet of lab and office space at the IZB Martinsried, one of Germany`s most vibrant biotechnology clusters.

Our operational set up, combined with Secarna`s talented staff and internationally accomplished scientific advisors enable us to write new chapters in the book of antisense oligonucleotide discovery and development.

Secarna`s mission is to maximize the performance and output of our proprietary LNAplus™ antisense oligonucleotide discovery platform, therewith developing highly specific, safe and efficacious antisense therapies for challenging or currently not druggable targets.